Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M98.4Revenue $M0Net Margin (%)0Z-Score1.0
Enterprise Value $M40.7EPS $-1.2Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %0Quick Ratio20.3Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio20.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-27.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-34.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M44.3ROI % (ttm)-69.7Gross Margin Increase y-yN

Gurus Latest Trades with CNDO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CNDOGeorge Soros 2014-09-30 Sold Out $1.48 - $2.16
($1.77)
$ 2.2225%Sold Out0
CNDOGeorge Soros 2014-06-30 Buy $1.55 - $2.02
($1.76)
$ 2.2226%New holding, 29279 sh.29,279
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CNDO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CNDO George Soros 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


CNDO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lu LucyCFO 2014-12-01Buy5,000$1.4553.1view
ROSENWALD LINDSAY A MDPresident and CEO, 10% Owner 2014-12-01Buy974$1.4553.1view
ROSENWALD LINDSAY A MDPresident and CEO, 10% Owner 2014-11-06Buy150,000$1.6137.89view
Hoenlein MalcolmDirector 2014-11-06Buy25,000$1.6137.89view
WEISS MICHAEL SExec. VC - Strategic Dev., 10% Owner 2014-11-06Buy1,000,000$1.6137.89view
Lu LucyCFO 2014-06-02Buy5,000$1.3762.04view
HORGAN KEVINFormer Chief Medical Officer 2014-04-22Sell47,566$1.8917.46view
HORGAN KEVINFormer Chief Medical Officer 2014-04-21Sell19,000$1.8122.65view
HORGAN KEVINFormer Chief Medical Officer 2014-04-17Sell101$1.8520view
Lu LucyCFO 2013-12-04Buy1,107$1.3959.71view

Press Releases about CNDO :

    Quarterly/Annual Reports about CNDO:

    News about CNDO:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight Jul 28 2013 
    Weekly CFO Buys Highlight Jul 21 2013 
    Weekly CFO Buys Highlight Jun 11 2013 
    Weekly CEO Buys Highlight: CNDO Jan 21 2013 
    Coronado Biosciences New CEO Makes First Buy of the Year, Worth $114K Jan 16 2013 
    Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO Jun 30 2012 
    Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO Jun 30 2012 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Dec 24 2014
    Coronado Biosciences Announces Closing of Initial Public Offering of CB Pharma Acquisition Corp. Dec 18 2014
    Coronado Biosciences Announces Closing of Initial Public Offering of CB Pharma Acquisition Corp. Dec 18 2014
    Coronado Biosciences Announces Pricing of Initial Public Offering of CB Pharma Acquisition Corp. Dec 15 2014
    Coronado Biosciences Announces Pricing of Initial Public Offering of CB Pharma Acquisition Corp. Dec 15 2014
    Coronado Biosciences, Inc. (CNDO) in Focus: Stock Soars 17.6% Nov 28 2014
    Coronado Biosciences (CNDO) Jumps: Stock Rises 8.5% Nov 25 2014
    Warren Buffett Pick CBI Tumbles On Rating Downgrade Nov 24 2014
    CORONADO BIOSCIENCES INC Financials Nov 15 2014
    Rackspace Bounces, Making Dan Loeb $34 Million In The Process Nov 11 2014
    CORONADO BIOSCIENCES INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial... Nov 10 2014
    Coronado Biosciences Raises $3,500,000 Through the Private Placement of Restricted Common Stock Nov 07 2014
    Coronado Biosciences Raises $3,500,000 Through the Private Placement of Restricted Common Stock Nov 07 2014
    CORONADO BIOSCIENCES INC Files SEC form 8-K, Other Events Nov 07 2014
    CORONADO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014
    Coronado Biosciences Reports Financial Results Nov 06 2014
    Coronado Biosciences Forms Subsidiary to Acquire and License Dermatology Products for... Oct 08 2014
    Kamada Plunges Following Missed Marks In Trial Sep 04 2014
    CORONADO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 11 2014
    Coronado Falls on TSO Study Results Jun 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK